|
|||||
|
|
P02-06. The adjuvancy of OX40 ligand (CD252) on an HIV-1 canarypox vaccine |
|
| Authors: | Liu J Ngai N Stone GW Yue F Ostrowski MA |
| Institution: | 1.DHVI and Surgery, Duke University Medical School, Durham, USA ;2.ImmunoTechnology Section, Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA ;3.Immunology Core Section, Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA ;4.Duke University Medical Center; DHVI and Surgery, Durham, NC, USA ;5.Department of Medicine, University of Alabama, Birmingham, AL, USA ;6.Department of Pediatrics, Duke University Medical Center, Durham, NC, USA ;7.Duke University Medical Center; DHVI and Medicine, Durham, NC, USA ;8.Duke University Medical Center; DHVI, Immunology and Surgery, Durham, NC, USA ;9.Department of Surgery, Duke University Medical Center, Durham, NC, USA ;10.Viral Pathogenesis Laboratory, Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA ;11.DHVI, Immunology, and Medicine, Duke University Medical Center, Durham, NC, USA ;12.Duke University Medical Center, DHVI, Surgery and Immunology, Durham, NC, USA ; |
| Abstract: | |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |